Carlsmed, Inc. (CARL)

Carlsmed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	43.43	40.13	7.22
Cash & Short-Term Investments	43.43	40.13	7.22
Cash Growth	-	455.59%	-
Receivables	8.12	6.77	3.17
Inventory	1.26	1	0.58
Prepaid Expenses	1.27	1.37	0.65
Restricted Cash	0.1	0.1	0.15
Total Current Assets	54.18	49.35	11.77
Property, Plant & Equipment	2.04	1.9	2.24
Long-Term Deferred Charges	1.5	0.4	-
Other Long-Term Assets	0.12	0.17	0.02
Total Assets	57.84	51.82	14.02
Accounts Payable	2.58	2.41	1.69
Accrued Expenses	5.32	5.96	3.6
Current Portion of Long-Term Debt	-	-	1.84
Current Portion of Leases	0.46	0.45	0.31
Total Current Liabilities	8.36	8.82	7.44
Long-Term Debt	15.42	15.41	7.47
Long-Term Leases	1.2	1.32	1.77
Other Long-Term Liabilities	0.73	0.68	0.1
Total Liabilities	25.72	26.23	16.78
Additional Paid-In Capital	0.29	0.54	0.78
Retained Earnings	-76.9	-71.17	-46.91
Total Common Equity	-76.61	-70.63	-46.13
Shareholders' Equity	32.12	25.6	-2.75
Total Liabilities & Equity	57.84	51.82	14.02
Total Debt	17.08	17.18	11.39
Net Cash (Debt)	26.35	22.95	-4.17
Net Cash Per Share	1.14	1.01	-0.19
Filing Date Shares Outstanding	23.99	23.63	21.69
Total Common Shares Outstanding	23.99	23.63	21.69
Working Capital	45.82	40.53	4.33
Book Value Per Share	-3.19	-2.99	-2.13
Tangible Book Value	-76.61	-70.63	-46.13
Tangible Book Value Per Share	-3.19	-2.99	-2.13
Machinery	0.65	0.58	0.4
Leasehold Improvements	0.08	0.08	0.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q